Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions.

Saved in:
Bibliographic Details
Title: Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions.
Authors: Pierre, Camille N.1,2 (AUTHOR), Adams, Lily E.3 (AUTHOR), Higgins, Jaclyn S.3 (AUTHOR), Anasti, Kara1,4 (AUTHOR), Goodman, Derrick1,5 (AUTHOR), Mielke, Dieter5 (AUTHOR), Stanfield-Oakley, Sherry5 (AUTHOR), Powers, John M.3,6 (AUTHOR), Li, Dapeng1,4 (AUTHOR), Rountree, Wes1,4 (AUTHOR), Wang, Yunfei1,4 (AUTHOR), Edwards, Robert J.1,4 (AUTHOR), Alam, S. Munir1,4 (AUTHOR), Ferrari, Guido1,5,7 (AUTHOR), Tomaras, Georgia D.1,5,7,8 (AUTHOR), Haynes, Barton F.1,4,8 (AUTHOR), Baric, Ralph S.6 (AUTHOR) rbaric@email.unc.edu, Saunders, Kevin O.1,5,7,8 (AUTHOR) rbaric@email.unc.edu
Source: PLoS Pathogens. 6/20/2024, Vol. 20 Issue 6, p1-23. 23p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15537366
DOI:10.1371/journal.ppat.1011569